Neusoft Medical

Neusoft Medical Systems Co., Ltd. (hereinafter referred to as "Neusoft Medical" or "the Company") is China's leading provider of medical imaging products and solutions, with a central state-owned enterprise (Genertec) as its largest shareholder. Rooted in China, the Company has established an extensive R&D, marketing, and service network globally, supplying nearly 100 product models covering all categories, grades, and customer segments to over 13,000 clients in more than 110 countries, with a historical installed base of over 47,000 units. As of 2023, the Company is China's largest CT manufacturer and exporter (by installed base and sales volume); its DSA and MRI product sales rank first and second domestically, respectively. The Company is committed to driving and leading industry development through independent R&D, having introduced milestone innovations such as China's first CT, first superconducting MRI, and first DR. After more than two decades of sustained investment and solid accumulation, the Company has achieved comprehensive breakthroughs in high-end products in recent years, launching China's first 512-slice ultra-high-end CT, the industry's first dual-energy 3.0T MRI, the world's first trackless suspended dual-center seven-axis angiography system, and the world's first 180ps-level fully digital PET/CT, among other products that rival international advanced standards, earning widespread recognition from over 500 top-tier hospitals in China and numerous renowned medical institutions overseas. Looking ahead, Neusoft Medical will leverage the solid support of the central enterprise platform to strive to build a "national team" of high-end medical equipment, become a trusted choice for customers, actively serve the Healthy China strategy, and make outstanding contributions to human health and well-being!